 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
Date |
Open |
High |
Low |
Close |
Volume |
07/07/2025 |
$3.33 |
$3.44 |
$3.33 |
$3.37 |
108.50K | 07/08/2025 |
$3.38 |
$3.47 |
$3.35 |
$3.38 |
164.20K | 07/09/2025 |
$3.42 |
$3.47 |
$3.32 |
$3.36 |
162.20K | 07/10/2025 |
$3.35 |
$3.38 |
$3.25 |
$3.27 |
113.80K | 07/11/2025 |
$3.26 |
$3.32 |
$3.12 |
$3.21 |
169.30K |
 |
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). Co. has two lead compounds, NRX-100, a proprietary presentation of ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. Co. is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. | |
 |

NRX Pharmaceuticals (NRXP) has the following price history information. Looking back at NRXP historical stock prices for the last five trading days, on July 07, 2025, NRXP opened at $3.33, traded as high as $3.44 and as low as $3.33, and closed at $3.37. Trading volume was a total of 108.50K shares. On July 08, 2025, NRXP opened at $3.38, traded as high as $3.47 and as low as $3.35, and closed at $3.38. Trading volume was a total of 164.20K shares. On July 09, 2025, NRXP opened at $3.42, traded as high as $3.47 and as low as $3.32, and closed at $3.36. Trading volume was a total of 162.20K shares. On July 10, 2025, NRXP opened at $3.35, traded as high as $3.38 and as low as $3.25, and closed at $3.27. Trading volume was a total of 113.80K shares. On July 11, 2025, NRXP opened at $3.26, traded as high as $3.32 and as low as $3.12, and closed at $3.21. Trading volume was a total of 169.30K shares.
NRXP Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into NRX Pharmaceuticals shares, starting with a $10,000 purchase of NRXP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/05/2017 |
|
End date: |
07/11/2025 |
|
Start price/share: |
$96.00 |
|
End price/share: |
$3.21 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-96.66% |
|
Average Annual Total Return: |
-36.05% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$334.49 |
|
Years: |
7.60 |
|
|
 |
Date |
Close |
07/07/2025 | $3.37 | 07/08/2025 | $3.38 | 07/09/2025 | $3.36 | 07/10/2025 | $3.27 | 07/11/2025 | $3.21 |
|
 |